The interaction between tumor cell PDPN and platelet CLEC-2 drives tyrosine phosphorylation of the Src family kinases (Syk) and phospholipase C gamma 2 (PLCγ2), resulting in platelet activation and aggregation [22, 31]. This evidence concerns the gene PLCG2 and neoplasm.